{Reference Type}: Case Reports
{Title}: Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: a case report.
{Author}: Jawad MD;Go RS;Ketterling RP;Begna KH;Reichard KK;Shi M;
{Journal}: Clin Case Rep
{Volume}: 4
{Issue}: 3
{Year}: Mar 2016
暂无{DOI}: 10.1002/ccr3.506
{Abstract}: Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.